- Report
- August 2025
- 195 Pages
Global
From €3160EUR$3,545USD£2,733GBP
€3511EUR$3,939USD£3,036GBP
- Report
- August 2025
- 185 Pages
Global
From €3160EUR$3,545USD£2,733GBP
€3511EUR$3,939USD£3,036GBP
- Report
- June 2026
- 271 Pages
Global
From €5215EUR$5,850USD£4,509GBP
- Report
- June 2026
- 383 Pages
Global
From €5215EUR$5,850USD£4,509GBP
- Report
- June 2026
- 386 Pages
Global
From €5215EUR$5,850USD£4,509GBP
- Report
- June 2026
- 308 Pages
Global
From €5215EUR$5,850USD£4,509GBP
- Report
- January 2026
- 186 Pages
Global
From €4011EUR$4,500USD£3,469GBP
- Report
- February 2026
- 250 Pages
Global
From €4002EUR$4,490USD£3,461GBP
- Report
- February 2026
- 250 Pages
Global
From €4002EUR$4,490USD£3,461GBP
- Report
- February 2026
- 250 Pages
Global
From €4002EUR$4,490USD£3,461GBP
- Report
- February 2026
- 250 Pages
Global
From €4002EUR$4,490USD£3,461GBP
- Report
- January 2026
- 181 Pages
Global
From €4011EUR$4,500USD£3,469GBP
- Report
- February 2026
- 250 Pages
Global
From €4002EUR$4,490USD£3,461GBP
- Report
- February 2026
- 250 Pages
Global
From €4002EUR$4,490USD£3,461GBP
- Report
- February 2026
- 250 Pages
Global
From €4002EUR$4,490USD£3,461GBP
- Report
- February 2026
- 250 Pages
Global
From €4002EUR$4,490USD£3,461GBP
- Report
- February 2026
- 250 Pages
Global
From €4002EUR$4,490USD£3,461GBP
- Report
- June 2026
- 386 Pages
Global
From €5215EUR$5,850USD£4,509GBP
- Report
- June 2026
- 274 Pages
Global
From €5215EUR$5,850USD£4,509GBP
- Report
- June 2026
- 282 Pages
Global
From €5215EUR$5,850USD£4,509GBP

The Autoimmune Disorder market is a subset of the Allergy and Immunology field. It focuses on the diagnosis and treatment of diseases caused by an overactive immune system. These diseases can affect any organ or tissue in the body, and can range from mild to life-threatening. Common autoimmune disorders include rheumatoid arthritis, lupus, multiple sclerosis, and type 1 diabetes. Treatment typically involves medications to suppress the immune system, as well as lifestyle changes to reduce inflammation.
The Autoimmune Disorder market is highly competitive, with many companies offering treatments and therapies. These include pharmaceutical companies such as AbbVie, Amgen, and Biogen, as well as biotechnology companies such as Gilead Sciences and Celgene. Additionally, there are a number of smaller companies that specialize in specific autoimmune disorders, such as Mylan and Alexion Pharmaceuticals. Show Less Read more